FCH
NBP

Freestone Capital Holdings’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Freestone Capital Holdings’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Hold
10,000
– – ﹤0.01% 623
2026
Q1 		$24.6K Hold
10,000
– – ﹤0.01% 569
2025
Q4 		$39.8K Hold
10,000
– – ﹤0.01% 552
2025
Q3 		$37.8K Hold
10,000
– – ﹤0.01% 536
2025
Q2 		$24.2K Hold
10,000
– – ﹤0.01% 454
2025
Q1 		$8.24K Hold
10,000
– – ﹤0.01% 444
2024
Q4 		$8.5K Hold
10,000
– – ﹤0.01% 441
2024
Q3 		$12.4K Buy
+10,000
New +$12.5K ﹤0.01% 437

Other funds holding NBP

AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Freestone Capital Holdings's NBP Position: Q2 2026 in Review

Freestone Capital Holdings held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 10,000 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

Freestone Capital Holdings first reported a position in NBP in Q3 2024 and has held it in 8 quarters since. The position peaked at $39.8K in Q4 2025. 6 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Freestone Capital Holdings held 10,000 shares of NovaBridge Biosciences American Depositary Shares worth $19.5K as of Q2 2026.
  • Freestone Capital Holdings left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Freestone Capital Holdings's portfolio in Q2 2026, its #623 holding.
  • Freestone Capital Holdings first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2024 and has held it in 8 quarters since.
  • Freestone Capital Holdings's NovaBridge Biosciences American Depositary Shares position peaked at $39.8K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.